Company

Opus Genetics, Inc. (IRD)

Standardized SEC financial data for Opus Genetics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001228627 · NASDAQ · Pharmaceutical Preparations.

Gross margin

-0.7%

Operating margin

-271.9%

Net margin

-349.3%

Revenue growth (YoY)

29.1%

Return on equity

-323.1%

Free cash flow

-$35.3M

Debt / equity

0.07×

Current ratio

6.43×

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$0	$589K	$39.9M	$19.0M	$11.0M	$14.2M
R&D expense	$6.6M	$15.2M	$14.4M	$17.7M	$26.9M	$30.8M
SG&A expense	$2.8M	$8.1M	$7.3M	$12.0M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$16.4M	$24.5M	$42.6M	$50.5M	$30.3M	$45.1M
Total current assets	$17.7M	$26.1M	$49.0M	$53.9M	$36.6M	$50.0M
Property, plant & equipment	$14K	$10K	$6K	$0

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$6.8M	-$19.4M	$14.3M	-$1.1M	-$25.6M	-$35.3M
Capital expenditures	$0	—	—	—	—	—
Free cash flow	-$6.8M	—	—	—	—

Get IRD data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/IRD/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/IRD/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View IRD filings on SEC EDGAR →